MarketInOut Stock Screener Log In | Sign Up

Rubicon Research Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:57
Rubicon Research Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization235,877 mln
Float51.32 mln
Earnings Date11/05/2026

EPS

17.36
Stretched

P / E

87.27
Speculative

Relative Strength

62 / 100
Outperforming

Debt / Equity

0.24
Very low leverage

Pre-Tax Margin

19%
Healthy margin

ROE

30.96
Very strong

Business Description

Rubicon Research Limited is an India-based specialty pharmaceutical company that develops and sells drug products across markets including the United States. Founded in 1999 and headquartered in Mumbai, the company has built its own drug delivery technologies that control how and when medicines are released in the body. Its work spans a wide range of treatment areas, from pain relief and heart health to digestive conditions and central nervous system disorders.

Key Fundamentals

EPS17.36
P/E87.27
ROE30.96
RPS120
ROIC22.26
ROA14.79
Interest Cover9.78
EBITDA, mln4,630
EV / EBITDA57.75
EV / EBIT64.87
Revenue, mln19,358
EV / Revenue13.81

Quote Details

Last 1,514.95
Change 24.3 (1.63%)
Open 1,493.00
Volume 8,101
Turnover 12,272,610
Average Volume 19,972

Financial Ratios

Pre-Tax Profit Margin19
Current Ratio2.01
Price / Book20.65
Price / Tangible Book21.73
Price / Free Cash Flow14,787
Debt / Equity0.24
Price / Sales13.81

Financial Strength

Altman Z-Score19.63
Price to Graham Number10.17

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.22% 87 / 100   
1 Month -9.81% 38 / 100   
2 Months 0.01% 70 / 100   
6 Months 61.57% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog